Related Experiment Video
Updated: Jun 17, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Ubiquitin: A double-edged sword in hepatitis B virus-induced hepatocellular carcinoma
Arpita Kar1, Sandipan Mukherjee1, Soumyadeep Mukherjee2
1Department of Signal Transduction & Biogenic Amines, Chittaranjan National Cancer Institute, Kolkata, India.
Abstract:
Hepatitis B virus is one of the leading causes behind the neoplastic transformation of liver tissue and associated mortality. Despite the availability of many therapies and vaccines, the pathogenic landscape of the virus remains elusive; urging the development of novel strategies based on the fundamental infectious and transformative modalities of the virus-host interactome. Ubiquitination is a widely observed post-translational modification of several proteins, which either regulates the proteins' turnover or impacts their functionalities. In recent years, ample amount of literature has accumulated regarding the ubiquitination dynamics of the HBV proteins as well as the host proteins during HBV infection and carcinogenesis; with direct and detailed characterization of the involvement of HBV in these processes. Interestingly, while many of these ubiquitination events restrict HBV life cycle and carcinogenesis, several others promote the emergence of hepatocarcinoma by putting the virus in an advantageous position. This review sums up the snowballing literature on ubiquitination-mediated regulation of the host-HBV crosstalk, with special emphasis on its influence on the establishment and progression of hepatocellular carcinoma on a molecular level. With the advent of cutting-edge ubiquitination-targeted therapeutic approaches, the findings emanating from this review may potentiate the identification of novel anti-HBV targets for the formulation of novel anticancer strategies to control the HBV-induced hepato-carcinogenic process on a global scale.
Insights
Ubiquitination plays a dual role in Hepatitis B virus (HBV) infection, influencing both viral progression and host cell transformation. Understanding these ubiquitination events is key to developing new treatments for HBV-induced liver cancer.
Area of Science:
- Virology
- Molecular Biology
- Cancer Research
Background:
- Hepatitis B virus (HBV) is a major cause of liver cancer and mortality worldwide.
- Despite existing therapies and vaccines, the precise mechanisms of HBV pathogenesis remain incompletely understood.
- Novel strategies targeting virus-host interactions are needed to combat HBV-related diseases.
Purpose of the Study:
- To review the current literature on ubiquitination's role in the Hepatitis B virus (HBV) host-pathogen interactome.
- To elucidate how ubiquitination events influence HBV infection, replication, and the development of hepatocellular carcinoma (HCC).
- To highlight potential therapeutic targets for novel anti-HBV and anti-cancer strategies.
Main Methods:
- Comprehensive literature review of studies investigating ubiquitination in HBV infection and hepatocellular carcinoma.
- Analysis of research detailing the ubiquitination of both viral and host proteins.
- Synthesis of findings on the dual role of ubiquitination in restricting or promoting HBV pathogenesis.
Main Results:
- Ubiquitination significantly impacts the turnover and function of viral and host proteins during HBV infection.
- Certain ubiquitination events restrict HBV replication and carcinogenesis, while others promote hepatocarcinoma development.
- The interplay between HBV and host ubiquitination machinery is crucial for viral persistence and oncogenesis.
Conclusions:
- Ubiquitination is a critical post-translational modification modulating the host-HBV crosstalk.
- Targeting specific ubiquitination pathways offers potential for developing new therapeutic interventions against HBV-induced liver cancer.
- Further research into ubiquitination dynamics can lead to novel strategies for controlling HBV-related hepato-carcinogenesis globally.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Intralumenal Vesicles and Multivesicular Bodies
Mechanisms of Retrovirus-induced Cancers
Export of Misfolded Proteins out of the ER

